data

Subscribe to data

Background

The European Commission (EC) issued the long-awaited adequacy decision for the new EU-U.S. Data Privacy Framework (Framework) on July 10, 2023. The Court of Justice of the European Union (CJEU) had previously invalidated both the U.S.-EU Safe Harbor in 2015, and the U.S.-EU Privacy Shield in 2020 after challenges by Austrian privacy activist Max Schrems (CJEU decisions known as Schrems I and Schrems II, respectively). Following those decisions President Biden signed Executive Order 14086 on “Enhancing Safeguards for United States Signals Intelligence Activities”, which introduced new binding safeguards. Our previous client alert discussed how the draft adequacy decision, including in relation to this this Executive Order, addressed concerns raised in Schrems II.Continue Reading Third Time’s a Charm: European Commission adopts EU-U.S. Data Privacy Framework

On June 27, 2023, the Council of Europe (“CoE”) announced the adoption of its first module of the Model Contractual Clauses (“MCCs”) for cross-border data transfers based on the Protocol amending the Convention for the Protection of Individuals with Regard to Automatic Processing of Personal Data (Convention 108+). These model clauses aim to regulate data flows between data controllers and are recommended for adoption by competent authorities.Continue Reading Convention 108+: The Council of Europe Releases Model Contractual Clauses for Global Data Transfers

On 7 June 2023, the European Union Agency for Cybersecurity (ENISA) released a report Multilayer Framework for Good Cybersecurity Practices for AI (“Framework”) in response to the evolving landscape of artificial intelligence (AI) and the associated cybersecurity challenges. The publication aims to establish a robust framework that promotes cybersecurity practices throughout the entire lifecycle of AI, ranging from conceptualization to decommissioning. This blog summarises the main features of the Framework.Continue Reading ENISA Releases Comprehensive Framework for Ensuring Cybersecurity in the Lifecycle of AI Systems

On 19 June 2023, the Information Commissioner’s Office (ICO) has released new Guidance on Privacy-Enhancing Technologies (PETs) for Data Protection Compliance. This guidance is designed to assist data protection officers (DPOs) and individuals responsible for managing large-scale personal data sets across diverse sectors, including finance, healthcare and research.Continue Reading Guidance on Privacy-Enhancing Technologies for Data Protection Compliance: Key Considerations for Organizations

In our previous post here we discussed the ICO’s announcement that it is working on new Standard Contractual Clauses (SCCs) to facilitate transfers of personal data outside the UK. The new UK SCCs will be known as the UK’s International Data Transfer Agreement (IDTA).

The ICO has now launched the public consultation on its IDTA and accompanying guidance (available here). The consultation is open for feedback until 5pm on 7 October 2021.

Purpose of the IDTA

The IDTA will replace the current UK SCCs. The ICO has already made it clear that any transfers to third countries will need to take into account the Schrems II decision and apply supplementary measures, where required. The IDTA is a contract which organisations will be able to use when making a ‘restricted transfer’. The ICO is also consulting on how to define a ‘restricted transfer’ in light of the UK GDPR. In particular, the ICO is consulting on whether to keep its current guidance that says a restricted transfer only takes place where the importer’s processing of the personal data is not subject to UK GDPR. Recognising the complexity of international transfers for businesses, the ICO Executive Director of Regulatory Strategy, Steve Wood, has said that the new guidance is designed to be accessible and to support the full range of organisations, from SMEs to multi-national companies.Continue Reading The UK’s ICO launches public consultation on new Standard Contractual Clauses

Last September the Singapore High Court heard a case relating to Singapore’s Personal Data Protection Act (PDPA). An individual had left his former employer, an investment company, to join a competitor firm. At this new firm, he sent an email to a client of his former employer’s, another individual, whom he had come to know…

The UK National Institute for Health and Care Excellence (NICE), along with the Care Quality Commission (CQC), Health Research Authority (HRA) and Medicines and Healthcare products Regulatory Agency (MHRA) have partnered to promote the use of artificial intelligence (AI) in health and care. The agencies are calling this initiative the “Multi-Agency Advisory Service for AI…

What is new?

During the ICO’s Data Protection Practitioners’ Conference 2021 today, the ICO revealed that it is working on new Standard Contractual Clauses (SCCs) to facilitate transfers of personal data outside the UK. The ICO’s consultation on the new UK SCCs will take place this summer. This is a separate process to the new SCCs that are currently being finalised by the European Commission. These new EU SCCs will not be valid for use for restricted transfers of data outside the UK.

Why is this change taking place?

From 31 December 2020 organisations in the UK have been relying on existing SCCs (Decisions 2001/497/EC and 2010/87/EU) for transfers of data outside the UK except where such territories are recognised as adequate (e.g. countries in the EU, the EEA, and those that obtained the EU Commission’s adequacy decision). However, the existing SCCs will be repealed when the new EU SCCs come into play. Therefore, the ICO is taking measures to put in place new international transfer mechanisms for restricted transfers outside the UK.Continue Reading ICO announces it is working on bespoke UK set of Standard Contractual Clauses

In this episode, Sarah Bruno and LiLing Poh discuss recent trends as organizations invest more in technology through the acquisition of new platforms or programs, or by working with a vendor to bring a product to market. Exploring a case study involving a global pharmaceutical company on the rollout of a health-related digital app,…